1. Home
  2. SMTI vs GNFT Comparison

SMTI vs GNFT Comparison

Compare SMTI & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMTI
  • GNFT
  • Stock Information
  • Founded
  • SMTI 1982
  • GNFT 1999
  • Country
  • SMTI United States
  • GNFT France
  • Employees
  • SMTI N/A
  • GNFT N/A
  • Industry
  • SMTI Medical/Dental Instruments
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SMTI Health Care
  • GNFT Health Care
  • Exchange
  • SMTI Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • SMTI 288.2M
  • GNFT 296.4M
  • IPO Year
  • SMTI N/A
  • GNFT 2019
  • Fundamental
  • Price
  • SMTI $34.39
  • GNFT $5.34
  • Analyst Decision
  • SMTI Buy
  • GNFT Strong Buy
  • Analyst Count
  • SMTI 1
  • GNFT 1
  • Target Price
  • SMTI $44.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • SMTI 24.7K
  • GNFT 16.6K
  • Earning Date
  • SMTI 11-12-2024
  • GNFT 09-19-2024
  • Dividend Yield
  • SMTI N/A
  • GNFT N/A
  • EPS Growth
  • SMTI N/A
  • GNFT N/A
  • EPS
  • SMTI N/A
  • GNFT 0.47
  • Revenue
  • SMTI $72,410,222.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • SMTI $26.97
  • GNFT $155.44
  • Revenue Next Year
  • SMTI $18.91
  • GNFT N/A
  • P/E Ratio
  • SMTI N/A
  • GNFT $11.96
  • Revenue Growth
  • SMTI 21.42
  • GNFT 175.45
  • 52 Week Low
  • SMTI $26.00
  • GNFT $3.08
  • 52 Week High
  • SMTI $43.25
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • SMTI 64.02
  • GNFT 47.15
  • Support Level
  • SMTI $32.91
  • GNFT $5.51
  • Resistance Level
  • SMTI $34.03
  • GNFT $5.81
  • Average True Range (ATR)
  • SMTI 1.39
  • GNFT 0.20
  • MACD
  • SMTI 0.24
  • GNFT -0.07
  • Stochastic Oscillator
  • SMTI 100.00
  • GNFT 0.00

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: